Pharmaceutical

KeyBioscience and Eli Lilly extend partnership for obesity treatments

KeyBioscience and Eli Lilly have extended their partnership to develop a new class of treatments for obesity and associated disorders.

Oct 12, 2024 - 04:00
KeyBioscience and Eli Lilly extend partnership for obesity treatments
KeyBioscience and Eli Lilly have extended their partnership to develop a new class of treatments for obesity and associated disorders.
Read the original article

Tags:

Previous Article

Booster Therapeutics to develop proteasome activator medicines

Next Article

CPHI Europe: Targeting supply chain bottlenecks key for cell and gene therapies

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Schizophrenia gene found to be linked to energy dysfunction in brain cells

STAT+: Schizophrenia gene found to be linked to energy ...

Aug 17, 2023

UBC to bolster safety functions with Oracle’s cloud technology

UBC to bolster safety functions with Oracle’s cloud tec...

Aug 2, 2023

Meloxicam fast acting by Viatris for Post-Operative Pai...

Dec 20, 2023